Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Tops Gainers in BCW Index for Second Straight Week

Stratagene led the BCW Index for the second week in a row with a gain of 4.3 percent for the five-day trading period ended Tuesday. Bio-Rad and Invitrogen were close behind, with shares of both companies up just over 4 percent for the week.

There were no significant declines for the week, with Qiagen leading that group with a drop of 2.8 percent. Overall, the Index gained .6 percent for the tracking period. In comparison, the Dow Jones Industrial Average dropped .2 percent, the Nasdaq fell .7 percent, and the Nasdaq Biotech Index declined 2.4 percent.

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(September 27, 2005)
Last Price
(September 20, 2005)
% Change
Agilent
A
33.46
34.03
-1.67
Applied Biosystems
ABI
22.75
23.07
-1.39
Beckman
BEC
54
54.06
-0.11
Bio-Rad
BIO
54.41
52.28
4.07
Bruker
BRKR
4.44
4.33
2.54
Fisher Scientific
FSH
62
63.01
-1.60
GE
GE
33.64
33.84
-0.59
Harvard Bio
HBIO
2.96
2.84
4.23
Invitrogen
IVGN
76.99
75.69
1.72
Molecular Devices
MDCC
20.23
20.32
-0.44
PerkinElmer
PKI
19.57
19.71
-0.71
Qiagen
QGEN
12.8
13.17
-2.81
Sigma
SIAL
62.54
60.34
3.65
Stratagene
STGN
8.89
8.52
4.34
Thermo
TMO
30.4
30.13
0.90
Waters
WAT
42.13
42.44
-0.73
Index Average  
33.83
33.61
0.64

 

 

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.